Pupillary response to methadone challenge in heroin users

Stephen T. Higgins, Maxine L Stitzer, Mary Elizabeth McCaul, George Bigelow, Ira A. Liebson

Research output: Contribution to journalArticle

Abstract

The relationship between self-reported illicit heroin use and pupillary response to a low-dose methadone challenge was examined in 28 men beginning methadone therapy for opiate dependence. Pupit diameter was assessed before and 60, 90, and 120 minutes after a 20 mg methadone dose on day 1 of treatment. Self-reports of opiate drug effects were also taken at these times. There was a significant negative correlation (r = -0.53) between pupillary constriction 120 minutes after drug dosing and the average dollar value of subjects' reported heroin use per week. In other words, those who showed the least pupillary constriction generally reported the highest amount of illicit heroin use. Total years since first opiate use was also a significant predictor of pupillary response (r = -0.46). Self-reported amount of heroin use and years since first opiate use together accounted for 60% of the total variance in pupillary response to the challenge (Mult r = 0.77). Pupillary response to a low-dose methadone challenge appears to be a clinically practical and objective method for determining opiate tolerance levels in applicants for methadone therapy.

Original languageEnglish (US)
Pages (from-to)460-463
Number of pages4
JournalClinical Pharmacology and Therapeutics
Volume37
Issue number4
StatePublished - Apr 1985

Fingerprint

Opiate Alkaloids
Methadone
Heroin
Constriction
Opioid-Related Disorders
Pharmaceutical Preparations
Self Report
Therapeutics

ASJC Scopus subject areas

  • Pharmacology

Cite this

Pupillary response to methadone challenge in heroin users. / Higgins, Stephen T.; Stitzer, Maxine L; McCaul, Mary Elizabeth; Bigelow, George; Liebson, Ira A.

In: Clinical Pharmacology and Therapeutics, Vol. 37, No. 4, 04.1985, p. 460-463.

Research output: Contribution to journalArticle

@article{88864a2be3554a2f88a4d6c8350cf43a,
title = "Pupillary response to methadone challenge in heroin users",
abstract = "The relationship between self-reported illicit heroin use and pupillary response to a low-dose methadone challenge was examined in 28 men beginning methadone therapy for opiate dependence. Pupit diameter was assessed before and 60, 90, and 120 minutes after a 20 mg methadone dose on day 1 of treatment. Self-reports of opiate drug effects were also taken at these times. There was a significant negative correlation (r = -0.53) between pupillary constriction 120 minutes after drug dosing and the average dollar value of subjects' reported heroin use per week. In other words, those who showed the least pupillary constriction generally reported the highest amount of illicit heroin use. Total years since first opiate use was also a significant predictor of pupillary response (r = -0.46). Self-reported amount of heroin use and years since first opiate use together accounted for 60{\%} of the total variance in pupillary response to the challenge (Mult r = 0.77). Pupillary response to a low-dose methadone challenge appears to be a clinically practical and objective method for determining opiate tolerance levels in applicants for methadone therapy.",
author = "Higgins, {Stephen T.} and Stitzer, {Maxine L} and McCaul, {Mary Elizabeth} and George Bigelow and Liebson, {Ira A.}",
year = "1985",
month = "4",
language = "English (US)",
volume = "37",
pages = "460--463",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Pupillary response to methadone challenge in heroin users

AU - Higgins, Stephen T.

AU - Stitzer, Maxine L

AU - McCaul, Mary Elizabeth

AU - Bigelow, George

AU - Liebson, Ira A.

PY - 1985/4

Y1 - 1985/4

N2 - The relationship between self-reported illicit heroin use and pupillary response to a low-dose methadone challenge was examined in 28 men beginning methadone therapy for opiate dependence. Pupit diameter was assessed before and 60, 90, and 120 minutes after a 20 mg methadone dose on day 1 of treatment. Self-reports of opiate drug effects were also taken at these times. There was a significant negative correlation (r = -0.53) between pupillary constriction 120 minutes after drug dosing and the average dollar value of subjects' reported heroin use per week. In other words, those who showed the least pupillary constriction generally reported the highest amount of illicit heroin use. Total years since first opiate use was also a significant predictor of pupillary response (r = -0.46). Self-reported amount of heroin use and years since first opiate use together accounted for 60% of the total variance in pupillary response to the challenge (Mult r = 0.77). Pupillary response to a low-dose methadone challenge appears to be a clinically practical and objective method for determining opiate tolerance levels in applicants for methadone therapy.

AB - The relationship between self-reported illicit heroin use and pupillary response to a low-dose methadone challenge was examined in 28 men beginning methadone therapy for opiate dependence. Pupit diameter was assessed before and 60, 90, and 120 minutes after a 20 mg methadone dose on day 1 of treatment. Self-reports of opiate drug effects were also taken at these times. There was a significant negative correlation (r = -0.53) between pupillary constriction 120 minutes after drug dosing and the average dollar value of subjects' reported heroin use per week. In other words, those who showed the least pupillary constriction generally reported the highest amount of illicit heroin use. Total years since first opiate use was also a significant predictor of pupillary response (r = -0.46). Self-reported amount of heroin use and years since first opiate use together accounted for 60% of the total variance in pupillary response to the challenge (Mult r = 0.77). Pupillary response to a low-dose methadone challenge appears to be a clinically practical and objective method for determining opiate tolerance levels in applicants for methadone therapy.

UR - http://www.scopus.com/inward/record.url?scp=0021919711&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021919711&partnerID=8YFLogxK

M3 - Article

C2 - 3979006

AN - SCOPUS:0021919711

VL - 37

SP - 460

EP - 463

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 4

ER -